ArticleRomanian journal of morphology and embryology = Revue roumaine de morphologie et embryologie
Pathology assessment of inflammatory bowel disease - prospective study from two referral centers.
Article in Romanian journal of morphology and embryology = Revue roumaine de morphologie et embryologie. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
13 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
We aimed to perform a comprehensive prospective histological analysis in a cohort of 40 inflammatory bowel disease (IBD) patients, both prior to and during biological therapy. The main objective was to establish the impact of histological activity in assessing treatment response and therapy guidance. Biopsy samples were assessed in two different stages of the disease course - before introduction of biological therapy and during follow-up (6-12 months later). Clinical, biochemical and endoscopic parameters were simultaneously gathered. By univariate analysis, presence of lymphoid aggregates, mucin depletion and ulcerations had a strong association with treatment response. IBD diagnosis >5 years and previous biological therapy were the most susceptible to treatment non-response. Nancy Index (NI) >1 is highly accurate, sensitive and specific in defining treatment responders. In addition to NI, high histological burden (mucin depletion, lymphoid aggregates and ulcerations) seems to predict treatment response in biological therapy-treated patients. Instead of a stringent "histological remission" goal, histological improvement of individual parameters might be a more reasonable goal, avoiding the risk of overtreatment. Further research is needed to assess histological burden in patients with endoscopic remission in order to stratify low- vs. high-risk "relapsers" and to avoid under- or over-treatment.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.